Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

TGF-β2 helps yak hair follicles enter the regression phase, while HSP70 tries to prevent it.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

The combination of azelaic acid, minoxidil, and caffeine significantly increased the survival of skin flaps by affecting certain body channels and nitric oxide levels.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

The fuzzy gene is crucial for controlling hair growth cycles.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The DNMT3B -579G>T polymorphism may increase the risk of colorectal cancer.

YWS1903 is safe for pregnant rats at moderate doses but causes fetal issues at high doses.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Radiation from a medical procedure caused temporary hair loss, but hair regrew with treatment.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.